autonomyo Sàrl

Autonomyo develops Skywalk, a wearable body-weight support system for gait rehabilitation. It enables stroke and neurological patients to train safely and more intensively across clinical and outpatient settings. Unlike fixed ceiling systems, Skywalk is mobile, easy to deploy, and supports therapists in increasing therapy time while reducing physical strain. FDA-listed in 2026, it is designed for scalable use in rehab clinics, outpatient centers, and home environments. Autonomyo targets large and growing neuro-rehabilitation markets in the US and Europe, addressing rising demand driven by aging populations and increasing incidence of neurological conditions.